Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
13,830,213
-
Share change
-
-23,811
-
Total reported value
-
$83,807,136
-
Put/Call ratio
-
38%
-
Price per share
-
$6.06
-
Number of holders
-
50
-
Value change
-
-$965,453
-
Number of buys
-
22
-
Number of sells
-
25
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q3 2020
As of 30 Sep 2020,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,830,213 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, Sonic Fund II, L.P., EVENTIDE ASSET MANAGEMENT, LLC, 683 Capital Management, LLC, BlackRock Inc., Solas Capital Management, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, STATE STREET CORP, and Russell Investments Group, Ltd..
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.